Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
暂无分享，去创建一个
M. Piccart | G. Hortobagyi | J. Baselga | H. Rugo | M. Gnant | B. Melichar | M. Campone | H. Burris | S. Noguchi | D. Lebwohl | K. Pritchard | D. Yardley | B. Pistilli | F. Erdkamp | K. Petráková | T. Taran | F. Arena | W. Harb | W. Feng | A. Cahana